Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001387131-21-008441 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-12 | 2021-08-10 | TXMD | Naughton Gail K | Dir | M - OptEx | — | +96.9K | 96.9K | New | — |
| D | 2021-08-12 | 2021-08-10 | TXMD | Naughton Gail K | Dir | M - OptEx | $0.00 | -96.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 96,864 | — | 96,864 | D | — | — | (F1) On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021. |
| 2 | Derivative | Restricted Stock Units | 2021-08-10 | M | D | 96,864 | $0.00 | 0 | D | $0.00 · — to — | 96,864 Common Stock | (F1) On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021. (F2) Each RSU represented a contingent right to receive one share of issuer common stock upon settlement. (F3) The RSUs vested on June 18, 2021. |